(Q45139318)

9 December 2017

Survivin expression is an independent poor prognostic marker in lung adenocarcinoma but not in squamous cell carcinoma (English)

1 reference

9 December 2017

1 reference

5

Sanghoon Jheon

1 reference

9 December 2017

6

Choon-Taek Lee

1 reference

9 December 2017

Ping-Li Sun

1

1 reference

9 December 2017

Yan Jin

2

1 reference

9 December 2017

Hyojin Kim

3

1 reference

9 December 2017

An Na Seo

4

1 reference

9 December 2017

Jin-Haeng Chung

7

1 reference

9 December 2017

2 August 2013

1 reference

9 December 2017

10

1 reference

inferred from page(s)

published in

Virchows Archiv

1 reference

9 December 2017

463

1 reference

9 December 2017

3

1 reference

9 December 2017

427-436

1 reference

https://scigraph.springernature.com/pub.10.1007/s00428-013-1462-9

9 December 2017

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1462-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1462-9

Non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1462-9

Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1462-9

Apoptosis and lung cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1462-9

Structural, functional and therapeutic biology of survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1462-9

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1462-9

Prognostic value of survivin in patients with non-small cell lung carcinoma: a systematic review with meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1462-9

Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1462-9

Survivin expression in pre-invasive lesions and non-small cell lung carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1462-9

Survivin gene expression in early-stage non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1462-9

Four deaths and a funeral: from caspases to alternative mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1462-9

The use of antisense oligonucleotides in evaluating survivin as a therapeutic target for radiation sensitization in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1462-9

Phase I and pharmacokinetic study of YM155, a small-molecule inhibitor of survivin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1462-9

Correlation between survivin expression and prognosis in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1462-9

A novel classification of lung cancer into molecular subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1462-9

Role of survivin in EGFR inhibitor-induced apoptosis in non-small cell lung cancers positive for EGFR mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1462-9

Role of ERK-BIM and STAT3-survivin signaling pathways in ALK inhibitor-induced apoptosis in EML4-ALK-positive lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1462-9

Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1462-9

High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1462-9

Detection of ALK gene rearrangement in non-small cell lung cancer: a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1462-9

Expression of survivin and patients survival in non-small cell lung cancer: a meta-analysis of the published studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1462-9

Differential expression of critical cellular genes in human lung adenocarcinomas and squamous cell carcinomas in comparison to normal lung tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1462-9

Squamous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-013-1462-9

Treat cancers by targeting survivin: just a dream or future reality?

21 January 2018

1 reference

12 December 2020

Survivin expression impacts prognostically on NSCLC but not SCLC

1 reference

12 December 2020

Survivin Expression in Atypical Adenomatous Hyperplasia of the Lung

1 reference

12 December 2020

The role of survivin on overall survival of non-small cell lung cancer, a meta-analysis of published literatures

1 reference

12 December 2020

Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer

1 reference

12 December 2020

10.1007/S00428-013-1462-9

Identifiers

DOI

1 reference

Dimensions Publication ID

9 December 2017

0 references

1 reference